ruthenium has been researched along with isoquinoline in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 2 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Guo, L; Li, X; Ma, Y; Su, X | 1 |
| Chen, J; Chen, L; Deng, Y; Li, B; Li, C; Lin, Y; Wang, J; Wang, T; Yang, D; Zhang, H | 1 |
| Cai, X; Chen, J; Chen, L; Chen, S; Chen, W; Guo, X; Li, B; Luo, H; Wang, J; Zhang, J | 1 |
3 other study(ies) available for ruthenium and isoquinoline
| Article | Year |
|---|---|
A mercuric ensemble based on a cycloruthenated complex as a visual probe for iodide in aqueous solution.
Topics: 2,2'-Dipyridyl; Colorimetry; Coordination Complexes; Iodides; Isoquinolines; Limit of Detection; Mercury; Mercury Compounds; Reagent Strips; Ruthenium; Spectrophotometry, Ultraviolet; Water | 2016 |
Novel cyclometalated Ru(II) complexes containing isoquinoline ligands: Synthesis, characterization, cellular uptake and in vitro cytotoxicity.
Topics: Animals; Antineoplastic Agents; Biological Transport; Cell Line, Tumor; Chemistry Techniques, Synthetic; Coordination Complexes; Humans; Isoquinolines; Ligands; Membrane Potential, Mitochondrial; Ruthenium; Zebrafish | 2020 |
Cyclometalated Ru(II)-isoquinoline complexes overcome cisplatin resistance of A549/DDP cells by downregulation of Nrf2 via Akt/GSK-3β/Fyn pathway.
Topics: Adaptor Proteins, Signal Transducing; Animals; Antineoplastic Agents; Apoptosis; Cell Cycle Checkpoints; Cell Proliferation; Cisplatin; Coordination Complexes; Dose-Response Relationship, Drug; Down-Regulation; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Glycogen Synthase Kinase 3 beta; Humans; Isoquinolines; Molecular Structure; NF-E2-Related Factor 2; Proto-Oncogene Proteins c-akt; Ruthenium; Structure-Activity Relationship; Tumor Cells, Cultured; Zebrafish | 2022 |